ReviewPublished 12 May 2026Uncertain magnitude of benefit of early second-generation androgen receptor antagonist treatment in advanced prostate cancerEmma K. van de Weerdt · Ashley J. Duits · Michael J. Samson · John-John B. SchnogOncology Reviewsdoi 10.3389/or.2026.1750202